Skip to main content
Program
#ScientificSessions26
Late-Breaking Science
Daily Coverage
Industry Highlights
Journeys
Site Map
2022
November
09
Early ablation bests medication in treatment naïve AFib patients
First-in-class aminopeptidase-A inhibitor fails to reduce treatment-resistant hypertension
#AHA 22 Closing Session: That’s a wrap
Page 1 of 1